Invention Grant
- Patent Title: 3-Aminopyrrolidines as inhibitors of monoamine uptake
- Patent Title (中): 3-氨基吡咯烷作为单胺摄取抑制剂
-
Application No.: US10558626Application Date: 2004-05-11
-
Publication No.: US07619096B2Publication Date: 2009-11-17
- Inventor: Christopher David Beadle , Manuel Javier Cases-Thomas , Barry Peter Clark , Peter Thaddeus Gallagher , John Joseph Masters , Graham Henry Timms , Magnus Wilhelm Walter , Maria Ann Whatton , Virginia Ann Wood , Jeremy Gilmore
- Applicant: Christopher David Beadle , Manuel Javier Cases-Thomas , Barry Peter Clark , Peter Thaddeus Gallagher , John Joseph Masters , Graham Henry Timms , Magnus Wilhelm Walter , Maria Ann Whatton , Virginia Ann Wood , Jeremy Gilmore
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Tonya L. Combs; Charles E. Cohen; Thomas E. Jackson
- Priority: GB0313463.2 20030611
- International Application: PCT/US2004/013004 WO 20040511
- International Announcement: WO2005/000811 WO 20050106
- Main IPC: C07D207/00
- IPC: C07D207/00 ; A61K31/40 ; C07D295/00 ; A01N43/36
Abstract:
The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, which are useful for the inhibition of the uptake of one or more physiologically active monoamines (serotonin, norepinephrine, and dopamine).
Public/Granted literature
- US20060270713A1 3-Aminopyrrolidines as inhibitors of monoamine uptake Public/Granted day:2006-11-30
Information query
